Processa Pharmaceuticals, Inc. (PCSA) stock

PCSANasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 5/30

$1.86+0.02 (+1.09%)

Close on Nov 13, 2026Market cap $5.20MP/E –Yield –

Processa Pharmaceuticals statistics

55 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: –
Last ex-dividend date: No dividends
Fundamentals through: Sep 30, 2026
Share price as of: Nov 13, 2026

Valuation ratiosIndustry

Market Cap: $5.20M; $272.32M
Enterprise Value: -$175.01M; $146.23M

Share statisticsIndustry

Shares Outstanding: 3M; 58M
Shares Change (QoQ): 0.17%; 0.50%
Shares Held by Institutions: 9.15%; 56.4%

Short sellingIndustry

Short Interest: 26,138; –
Short Interest Change: -43.8%; -0.80%
Short % of Shares Outstanding: 0.94%; 6.30%
Days to Cover: 1.00; 5.15

Stock price statisticsIndustry

52-Week High: $8.88; –
52-Week Low: $1.04; –
20-Day Moving Average: $1.85; –
50-Day Moving Average: $1.81; –
200-Day Moving Average: $2.29; –
Average True Range (14): $0.15; –
Price Change (1 Week): -3.63%; -1.15%
Price Change (1 Month): 10.7%; -4.87%
Price Change (3 Months): -12.7%; -21.0%
Price Change (6 Months): -37.2%; -20.6%
Price Change (YTD): -35.4%; -23.6%
Price Change (1 Year): -77.2%; -22.4%
Price Change (3 Years): -99.1%; -29.5%
Price Change (5 Years): -99.9%; -77.9%
Price Change (10 Years): -100.0%; -65.4%
Average Volume (10 Days): 23,643; –
Average Volume (20 Days): 26,219; –
Average Volume (90 Days): 205,065; –
Relative Volume: 0.09; 0.70
Relative Strength Index (14): 51.3; 43.4
Volatility (1 Year): 174.8%; 80.1%
Beta (5 Years): 0.80; 1.07

Returns on capitalIndustry

Return on Assets (ROA): -203.8%; -40.6%
Return on Capital Employed (ROCE): -107.4%; -37.9%

Financial positionIndustry

Current Ratio: 97.70; 3.30
Quick Ratio: 96.73; 2.39

EfficiencyIndustry

Profits Per Employee: -$16.10M; -$689.41K
Employee Count: 12; 74
WACC: 9.11%; 10.2%

Income statement (TTM)Industry

Operating Income: -$193.50M; -$21.37M
Net Income: -$193.16M; -$22.35M
EBITDA: -$193.50M; -$17.21M
EPS (Diluted): -$65.51; -$0.76

Balance sheetIndustry

Cash & Short-Term Investments: $180.21M; $68.68M
Net Cash (Debt): $180.21M; $17.76M
Net Cash Per Share: $64.51; $0.80
Equity (Book Value): -$181.38M; $53.89M
Book Value Per Share: -$64.93; $1.50
Tangible Book Value: -$181.38M; $27.13M
Working Capital: $180.15M; $79.99M

Cash flow (TTM)Industry

Operating Cash Flow: -$13.66M; -$12.38M

Dividends and yieldsIndustry

Earnings Yield: -3717.7%; -21.8%
Buyback Yield: -68.1%; -0.76%
Shareholder Yield: -68.1%; 0.00%

Scores and fair valueIndustry

Altman Z-Score: -2.88; 0.23
Piotroski F-Score: 4; 4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

Period	PCSA	S&P 500	Difference	PCSA per year	S&P 500 per year
1 month	+5.1%	-3.0%	+8.1 pts
3 months	-25.6%	-2.8%	−22.8 pts
Year to date	-35.4%	+11.5%	−46.9 pts
1 year	-74.5%	+13.5%	−88.0 pts
3 years	-99.0%	+77.7%	−176.7 pts	-78.6%	+21.1%
5 years	-99.9%	+72.6%	−172.6 pts	-77.8%	+11.5%
10 years	-100.0%	+308.2%	−408.1 pts	-53.5%	+15.1%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M PCSA shares were sold short on Oct 30, 2026, down 43.8% from the previous report. At recent volumes it would take 1.0 days to buy them back. Over the last 20 sessions, 42.4% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	26,138	-43.8%	27,704	1.0
Oct 15, 2026	46,488	+1022.9%	329,090	1.0
Sep 30, 2026	4,140	-72.4%	23,095	1.0
Sep 15, 2026	14,995	-58.3%	29,028	1.0
Aug 31, 2026	35,949	-46.6%	35,705	1.0
Aug 14, 2026	67,319	-68.8%	78,571	1.0
Jul 31, 2026	215,851	+108.4%	953,671	1.0
Jul 15, 2026	103,554	+20.3%	74,139	1.4
Jun 30, 2026	86,054	-4.4%	43,464	2.0
Jun 15, 2026	89,983	-1.2%	78,796	1.1
May 29, 2026	91,063	-21.9%	56,774	1.6
May 15, 2026	116,594	-13.9%	60,842	1.9

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?